BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28379235)

  • 1. Characterizing serum metabolic alterations of Alzheimer's disease and intervention of Shengmai-San by ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry.
    Lu S; Han Y; Chu H; Kong L; Zhang A; Yan G; Sun H; Wang P; Wang X
    Food Funct; 2017 Apr; 8(4):1660-1671. PubMed ID: 28379235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
    Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary and plasmatic metabolomics strategy to explore the holistic mechanism of lignans in S. chinensis in treating Alzheimer's disease using UPLC-Q-TOF-MS.
    Wei M; Liu Z; Liu Y; Li S; Hu M; Yue K; Liu T; He Y; Pi Z; Liu Z; Song F
    Food Funct; 2019 Sep; 10(9):5656-5668. PubMed ID: 31433414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying quality-markers from Shengmai San protects against transgenic mouse model of Alzheimer's disease using chinmedomics approach.
    Zhang AH; Yu JB; Sun H; Kong L; Wang XQ; Zhang QY; Wang XJ
    Phytomedicine; 2018 Jun; 45():84-92. PubMed ID: 29685366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic and urinary metabolomics studies on the mechanism of Schisandra polysaccharide in the treatment of Alzheimer's disease.
    Liu Y; Liu Z; Wei M; Hu M; Yue K; Bi R; Zhai S; Pi Z; Song F; Liu Z
    Food Funct; 2019 Jan; 10(1):432-447. PubMed ID: 30623955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
    Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
    J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of multiple constituents in Kai-Xin-San prescription and rat plasma after oral administration by liquid chromatography with quadrupole time-of-flight tandem mass spectrometry.
    Zhang X; Li Q; Lv C; Xu H; Liu X; Sui Z; Bi K
    J Sep Sci; 2015 Jun; 38(12):2068-75. PubMed ID: 25845859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and urine metabolomics based on UPLC-QTOF/MS reveal the effect and potential mechanism of "schisandra-evodia" herb pair in the treatment of Alzheimer's disease.
    Pang C; Wang R; Liu K; Yuan X; Ni J; Cao Q; Chen Y; Dong PL; Han H
    Biomed Chromatogr; 2024 Jul; 38(7):e5882. PubMed ID: 38649307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A UPLC-TOF/MS-based metabolomics study of rattan stems of Schisandra chinensis effects on Alzheimer's disease rats model.
    Yang BY; Tan JY; Liu Y; Liu B; Jin S; Guo HW; Kuang HX
    Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28664556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UHPLC-QTOF/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer's disease cell model induced by Aβ
    Zhang M; Liu Y; Liu M; Liu B; Li N; Dong X; Hong Z; Chai Y
    Metabolomics; 2019 Jan; 15(2):13. PubMed ID: 30830431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Different processed products of Polygonati Rhizoma treat Alzheimer's disease in rats: urine metabolomics based on UPLC-Q/TOF-MS].
    Zhu N; Zhu XD; Yang YS; Yan FX; Zhang P; Wan LC; Wu Y; Huang LP
    Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(24):6663-6675. PubMed ID: 38212026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explore the effects of Huang-Lian-Jie-Du-Tang on Alzheimer's disease by UPLC-QTOF/MS-based plasma metabolomics study.
    Sun LM; Zhu BJ; Cao HT; Zhang XY; Zhang QC; Xin GZ; Pan LM; Liu LF; Zhu HX
    J Pharm Biomed Anal; 2018 Mar; 151():75-83. PubMed ID: 29310050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UPLC-Q-TOF/MS based serum and urine metabolomics strategy to analyze the mechanism of nervonic acid in treating Alzheimer's disease.
    Chen Z; Liu S; Zhou H; Wang M; Pei S; Wang R; Liu Z
    J Pharm Biomed Anal; 2024 Mar; 240():115930. PubMed ID: 38157740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated study on the comprehensive mechanism of
    Fu J; Li J; Sun Y; Liu S; Song F; Liu Z
    Food Funct; 2023 Jan; 14(2):734-745. PubMed ID: 36562313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid screening of active ingredients and action mechanisms of Ecliptae Herba for treating Alzheimer's disease by UPLC-Q-TOF/MS and "component-target-pathway" network.
    Wei J; Wang Y; Wang X; Zhang Y; Zheng Y; Shao J; Cheng W; Li Y
    Fitoterapia; 2023 Sep; 169():105613. PubMed ID: 37454776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetic study of the components in Alpinia oxyphylla Miq.-Schisandra chinensis (Turcz.) Baill. herb pair and its single herb between normal and Alzheimer's disease rats by UPLC-MS/MS.
    Qi Y; Cheng X; Jing H; Yan T; Xiao F; Wu B; Bi K; Jia Y
    J Pharm Biomed Anal; 2020 Jan; 177():112874. PubMed ID: 31542420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the radical scavengers in the traditional Chinese medicine formula shengmai san by HPLC-DAD coupled with chemiluminescence (CL) and ESI-MS/MS.
    Wu L; Ding XP; Zhu DN; Yu BY; Yan YQ
    J Pharm Biomed Anal; 2010 Aug; 52(4):438-45. PubMed ID: 20137877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A metabolomic study of the urine of rats with Alzheimer's disease and the efficacy of Ding-Zhi-Xiao-Wan on the afflicted rats.
    He Y; Wang Y; Liu S; Pi Z; Liu Z; Xing J; Zhou H
    J Sep Sci; 2020 Apr; 43(8):1458-1465. PubMed ID: 32039552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems pharmacology-based mechanism exploration of Acanthopanax senticosusin for Alzheimer's disease using UPLC-Q-TOF-MS, network analysis, and experimental validation.
    Zhuo Y; Fu X; Jiang Q; Lai Y; Gu Y; Fang S; Chen H; Liu C; Pan H; Wu Q; Fang J
    Eur J Pharmacol; 2023 Sep; 954():175895. PubMed ID: 37422122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic study of the intervention effects of Shuihonghuazi Formula, a Traditional Chinese Medicinal formulae, on hepatocellular carcinoma (HCC) rats using performance HPLC/ESI-TOF-MS.
    Bao Y; Wang S; Yang X; Li T; Xia Y; Meng X
    J Ethnopharmacol; 2017 Feb; 198():468-478. PubMed ID: 28108381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.